Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07223177 · ClinicalTrials.gov registry record · NA
Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations
A NA study of SpO2, sponsored by Masimo Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT07223177 is a NA study of SpO2 that is actively recruiting participants, run by Masimo Corporation. The registered enrollment target is 100 participants. The trial reports 2 study locations across 1 state.
The verdict
NCT07223177, a NA study of SpO2, is actively recruiting participants, sponsored by Masimo Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pediatric sensors within their respective indicated patient populations that have a range of different skin pigmentations, simultaneously with an FDA cleared pulse oximeter as a comparator.
Conditions Studied
Interventions
- DEVICE Masimo Sensor (RD SET and/or LNCS) connected to Philips Monitor using Philips FAST SpO2 Algorithm
Study Locations (2)
California
- Paradigm Clinical Research - Modesto
- Paradigm Clinical Research - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2026-06-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07223177
The ClinicalTrials.gov registry entry for NCT07223177 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with SpO2 appearing as the primary indexed condition, and to 1 intervention - of which Masimo Sensor (RD SET and/or LNCS) connected to Philips Monitor using Philips FAST SpO2 Algorithm is the first listed.
NCT07223177 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07223177 about?
NCT07223177 is a clinical study titled "Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations". The objective of this study is to verify the form, fit and function of the Philips FAST technology with Masimo neonatal, infant and pediatric sensors for SpO2 monitoring in the respective indicated populations. The study design uses convenience sample data collection from neonatal, infant, and pedia...
What is the current status of trial NCT07223177?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-17. Estimated completion is 2026-06-05.
What conditions does trial NCT07223177 study?
This clinical trial studies the following conditions: SpO2.
What interventions are being tested in trial NCT07223177?
The interventions under investigation include: Masimo Sensor (RD SET and/or LNCS) connected to Philips Monitor using Philips FAST SpO2 Algorithm (DEVICE).
Who is sponsoring clinical trial NCT07223177?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07223177 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SpO2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.